Mobile Vision Clinics Enable Successful Rare Eye Disease Trial Enrollment During Pandemic
核心洞察
AGTC (搜索) partnered with 20/20 Onsite (搜索) to deploy Mobile Vision Clinics, successfully conducting 150 assessments across 24 states for rare eye disease trials during COVID-19 (搜索) restrictions.
The innovative mobile clinic approach helped surpass enrollment goals with 14 participants in the SKYLINE (搜索) trial for X-linked Retinitis Pigmentosa (搜索) and Achromatopsia (搜索).
Patient satisfaction reached 97% for the mobile vision services, demonstrating the viability of point-of-need assessments in clinical trials.
In a groundbreaking approach to clinical trial management during the COVID-19 (搜索) pandemic, Applied Genetic Technologies Corporation (搜索) (AGTC (搜索)) successfully overcame enrollment challenges by implementing mobile vision assessment units for rare eye disease studies.
Innovative Mobile Solution for Trial Continuation
Facing significant enrollment hurdles for their SKYLINE (搜索) trial investigating treatments for X-linked Retinitis Pigmentosa (搜索) (XLRP (搜索)) and Achromatopsia (搜索) (ACHM (搜索)), AGTC (搜索) partnered with 20/20 Onsite (搜索) to develop a novel solution. The collaboration resulted in the deployment of Mobile Vision Clinics (MVCs), bringing advanced ophthalmic assessments directly to patients' homes.
Impressive Reach and Enrollment Success
The mobile clinic initiative demonstrated remarkable success, completing 150 vision assessments across 24 states. This extensive geographical coverage enabled AGTC (搜索) to exceed their enrollment targets, successfully recruiting 14 participants for the trial. The mobile approach proved particularly valuable during pandemic-related travel restrictions and site limitations that would have otherwise severely impacted trial progress.
Patient-Centric Approach Yields High Satisfaction
The innovative service received overwhelming positive feedback, with 97% of participants expressing satisfaction with the convenience and safety of the mobile vision assessments. This high approval rate validates the effectiveness of point-of-need clinical services in maintaining trial momentum while prioritizing patient comfort and safety.
Impact on Clinical Trial Operations
The successful implementation of MVCs represents a significant advancement in clinical trial methodology, particularly for rare disease studies where patient populations are geographically dispersed. By bringing sophisticated ophthalmic equipment directly to participants, AGTC (搜索) avoided costly delays and maintained critical research timelines despite pandemic-related challenges.
The mobile vision clinic model established during this trial offers valuable insights for future clinical research, demonstrating how innovative approaches to patient assessment can overcome logistical barriers while maintaining high standards of clinical evaluation.